KRRO
KRRO
NASDAQ · Biotechnology

Korro Bio Inc

Biotech Stocks Healthcare Stocks
$12.05
-0.84 (-6.52%)
As of May 16, 2:12 AM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 13 81%
Hold 3 19%
Sell 0 0%
Price Target
Analyst Price Target -66.5% upside
Low Target $2.50
Average Target $4.04
High Target $4.74
Current Price $12.05
Current
$12.05
Target
$4.04
$2.50 $4.04 avg $4.74
Scenario Analysis
Bear Case
$2.50
-79.3%
Low target
Base Case
$4.04
-66.5%
Avg target
Bull Case
$4.74
+-60.7%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$55.89
-78.4% from high
52-Week Low
$5.20
+131.5% from low
Target vs 52W High
$4.04
-92.8% vs high
Next Earnings Report
May 19, 2026
1d
tomorrow
EPS Est: $-1.88
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
 Buy 43 56% $91.45 -52.6%